In vivo control of NF-kappa B activation by I kappa B alpha - PubMed (original) (raw)
In vivo control of NF-kappa B activation by I kappa B alpha
N R Rice et al. EMBO J. 1993 Dec.
Abstract
The transcription factor NF-kappa B is stored in the cytoplasm in complexes with the inhibitor protein I kappa B alpha. It has been shown in vitro that dissociation of I kappa B alpha from these complexes results in active NF-kappa B. In this report we show that lipopolysaccharide (LPS)-induced activation of B or pre-B cells results in loss of I kappa B alpha from NF-kappa B complexes in vivo. Many liberated NF-kappa B dimers reached the nucleus, where increased c-rel, p65 and p50 were detected by immunoblotting and by DNA binding assays. Some liberated dimers were retained in the cytoplasm, however, through binding to newly synthesized I kappa B alpha, a finding which strongly suggests (i) that the LPS-induced signal causes dissociation of complexes rather than preventing their association and (ii) that dissociation results from modification of I kappa B alpha and not of c-rel or p65. No effect of LPS treatment was detected on p105 or p100, which also retain rel family members in the cytoplasm. Quite unexpectedly, we also found that in unstimulated cells there is a constant ongoing process of degradation and replacement of complexed I kappa B alpha. We propose that this turnover results in the low level of active NF-kappa B presumably necessary even in the unstimulated cell, and that the high rate of synthesis of I kappa B alpha provides the ability to turn off NF-kappa B activity rapidly as soon as the activating signal ceases.
Similar articles
- The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers.
Ernst MK, Dunn LL, Rice NR. Ernst MK, et al. Mol Cell Biol. 1995 Feb;15(2):872-82. doi: 10.1128/MCB.15.2.872. Mol Cell Biol. 1995. PMID: 7823953 Free PMC article. - NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
Scheinman RI, Beg AA, Baldwin AS Jr. Scheinman RI, et al. Mol Cell Biol. 1993 Oct;13(10):6089-101. doi: 10.1128/mcb.13.10.6089-6101.1993. Mol Cell Biol. 1993. PMID: 8413211 Free PMC article. - I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA, Sun SC, Greene WC, Ballard DW. Ganchi PA, et al. Mol Biol Cell. 1992 Dec;3(12):1339-52. doi: 10.1091/mbc.3.12.1339. Mol Biol Cell. 1992. PMID: 1493333 Free PMC article. - Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Verma IM, et al. Genes Dev. 1995 Nov 15;9(22):2723-35. doi: 10.1101/gad.9.22.2723. Genes Dev. 1995. PMID: 7590248 Review. No abstract available.
Cited by
- Review on Additives in Hydrogels for 3D Bioprinting of Regenerative Medicine: From Mechanism to Methodology.
Fang W, Yang M, Liu M, Jin Y, Wang Y, Yang R, Wang Y, Zhang K, Fu Q. Fang W, et al. Pharmaceutics. 2023 Jun 9;15(6):1700. doi: 10.3390/pharmaceutics15061700. Pharmaceutics. 2023. PMID: 37376148 Free PMC article. Review. - Morinda umbellata active fraction inhibits lipopolysaccharide induced proinflammatory cytokines by downregulating NF-κB activation.
Krishnakumar NM, Manikantan K, Suja SNR, Latha PG, Ceasar SA. Krishnakumar NM, et al. Toxicol Res (Camb). 2022 Sep 8;11(5):841-851. doi: 10.1093/toxres/tfac063. eCollection 2022 Oct. Toxicol Res (Camb). 2022. PMID: 36337241 Free PMC article. - Using the Pleiotropic Characteristics of Curcumin to Validate the Potential Application of a Novel Gene Expression Screening Platform.
Liao SC, Hsu HW, Chuang KL, Huang ZY, Lin KT, Hsu WH, Chang KH, Huang CF, Su CL. Liao SC, et al. Nutrients. 2019 Jun 21;11(6):1397. doi: 10.3390/nu11061397. Nutrients. 2019. PMID: 31234318 Free PMC article. - Total flavonoids of Hedyotis diffusa Willd inhibit inflammatory responses in LPS-activated macrophages via suppression of the NF-κB and MAPK signaling pathways.
Chen Y, Lin Y, Li Y, Li C. Chen Y, et al. Exp Ther Med. 2016 Mar;11(3):1116-1122. doi: 10.3892/etm.2015.2963. Epub 2015 Dec 29. Exp Ther Med. 2016. PMID: 26998046 Free PMC article. - Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ, Yun J, Lee CW, Nam KH, Kim Y, Han SB, Yu J, Rho J, Kang JS. Kang MR, et al. Mar Drugs. 2014 Nov 24;12(11):5643-56. doi: 10.3390/md12115643. Mar Drugs. 2014. PMID: 25421321 Free PMC article.
References
- J Virol. 1992 Jun;66(6):3758-67 - PubMed
- Mol Cell Biol. 1992 Feb;12(2):444-54 - PubMed
- Nature. 1992 Aug 13;358(6387):597-9 - PubMed
- Genes Dev. 1992 Oct;6(10):1899-913 - PubMed
- Cell. 1992 Oct 16;71(2):243-53 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials